Literature DB >> 24468897

Not left ventricular lead position, but the extent of immediate asynchrony reduction predicts long-term response to cardiac resynchronization therapy.

Wolfram C Poller1, Henryk Dreger, Marius Schwerg, Hansjürgen Bondke, Christoph Melzer.   

Abstract

Cardiac resynchronization therapy (CRT) is an effective treatment for a large subgroup of chronic heart failure patients. Various attempts to improve the high non-responder rate of 30 % by preoperative asynchrony assessment have failed. We hypothesized that superior response to CRT is correlated with greater acute reduction of asynchrony and that a concordant left ventricular (LV) lead is beneficial compared to a discordant lead. Hundred and eight consecutive CRT patients from our center were prospectively included. Clinical status and asynchrony parameters were assessed before, 1 day and 6 months after CRT implantation. Super-response was defined as an increase of the LV ejection fraction by ≥15 % and a decrease in LV end systolic volume (LVESV) by ≥30 %. When the criteria for super-response were not met, average response was given with a decrease of baseline LVESV ≥15 %. Sixty eight patients were classified as responders (63 %). Comparing super- (n = 19) and average (n = 49) responders, we found that greater acute reduction of LV asynchrony (change of asynchronous segments under CRT: -1.3 vs. -0.4, p < 0.05; decrease of LV intraventricular delay: -34 ms vs. -16 ms, p < 0.05) is associated with superior reverse remodeling after 6 months. Importantly, asynchrony parameters of super-, average and non-responders were almost identical at baseline. A concordant LV lead (n = 63) was not associated with improved LV reverse remodeling compared to a discordant lead (n = 28): LVEF: +8.6 % vs. +7.8 %, p = 0.91; LVESV: -30.5 ml vs. -23.8 mL, p = 0.84. A greater immediate reduction of LV asynchrony predicts superior response. Preoperative asynchrony parameters do not correlate with outcome. A concordant LV lead is not superior to a discordant lead.

Entities:  

Mesh:

Year:  2014        PMID: 24468897     DOI: 10.1007/s00392-014-0672-8

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  42 in total

1.  Echocardiographic modeling of cardiac dyssynchrony before and during multisite stimulation: a prospective study.

Authors:  S Cazeau; P Bordachar; G Jauvert; A Lazarus; C Alonso; M C Vandrell; J Mugica; P Ritter
Journal:  Pacing Clin Electrophysiol       Date:  2003-01       Impact factor: 1.976

2.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

Review 3.  Dual- versus single-coil implantable defibrillator leads: review of the literature.

Authors:  Jörg Neuzner; Jörg Carlsson
Journal:  Clin Res Cardiol       Date:  2012-01-10       Impact factor: 5.460

4.  Identification and characterization of super-responders after cardiac resynchronization therapy.

Authors:  Patricia Reant; Amira Zaroui; Erwan Donal; Aude Mignot; Pierre Bordachar; Antoine Deplagne; Aude Solnon; Philippe Ritter; Jean-Claude Daubert; Jacques Clementy; Christophe Leclercq; Raymond Roudaut; Gilbert Habib; Stephane Lafitte
Journal:  Am J Cardiol       Date:  2010-05-01       Impact factor: 2.778

5.  Effect of left ventricular lead concordance to the delayed contraction segment on echocardiographic and clinical outcomes after cardiac resynchronization therapy.

Authors:  Jeffrey W H Fung; Yat-Yin Lam; Qing Zhang; Gabriel W K Yip; Winnie W L Chan; Gary C P Chan; Joseph Y S Chan; Cheuk-Man Yu
Journal:  J Cardiovasc Electrophysiol       Date:  2008-11-21

6.  Characterization of super-response to cardiac resynchronization therapy.

Authors:  John Rickard; Dharam J Kumbhani; Zoran Popovic; David Verhaert; Mahesh Manne; Daniel Sraow; Bryan Baranowski; David O Martin; Bruce D Lindsay; Richard A Grimm; Bruce L Wilkoff; Patrick Tchou
Journal:  Heart Rhythm       Date:  2010-04-08       Impact factor: 6.343

7.  Comparing outcome of patients with coronary artery disease and dilated cardiomyopathy in ICD and CRT recipients: data from the German DEVICE-registry.

Authors:  Kristina Wasmer; Julia Köbe; Dietrich Andresen; Ralf Zahn; Stefan G Spitzer; Joachim Jehle; Johannes Brachmann; Christoph Stellbrink; Eimo Martens; Matthias Hochadel; Jochen Senges; Helmut Klein; Lars Eckardt
Journal:  Clin Res Cardiol       Date:  2013-03-30       Impact factor: 5.460

8.  The risk of delayed atrioventricular and intraventricular conduction block following ablation of bundle branch reentry.

Authors:  Christopher Reithmann; Bernhard Herkommer; Adrien Huemmer; Franz von Hoch; Michael Fiek
Journal:  Clin Res Cardiol       Date:  2012-09-27       Impact factor: 5.460

9.  Subcellular structures and function of myocytes impaired during heart failure are restored by cardiac resynchronization therapy.

Authors:  Frank B Sachse; Natalia S Torres; Eleonora Savio-Galimberti; Takeshi Aiba; David A Kass; Gordon F Tomaselli; John H Bridge
Journal:  Circ Res       Date:  2012-01-17       Impact factor: 17.367

10.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

View more
  1 in total

1.  Outcome of super-responders to cardiac resynchronization therapy defined by endpoint-derived parameters of left ventricular remodeling: a two-center retrospective study.

Authors:  David Hürlimann; Susann Schmidt; Burkhardt Seifert; Ardan M Saguner; Gerhard Hindricks; Thomas F Lüscher; Frank Ruschitzka; Jan Steffel
Journal:  Clin Res Cardiol       Date:  2014-10-10       Impact factor: 5.460

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.